Bleeding time in uremia: a useful test to assess clinical bleeding.
Modified Ivy bleeding time (template) and platelet aggregation to ADP, epinephrine, and collagen were studied in 26 uremic patients who had not recently ingested anti-platelet drugs. Regardless of the aggregating agent used, the abnormalities in platelet aggregation were often mild, even with advanced uremia, and frequently less severe than the effects of common anti-platelet drugs. The inhibition of collagen-induced aggregation was significantly correlated with both increased bleeding time and blood urea nitrogen. Platelet aggregation was not discriminative between clinically bleeding and non-bleeding groups of patients, but the bleeding time was helpful in this regard. In certain cases, the aggregometric patterns differed between drug-induced and uremic thrombocytopathies. Platelet aggregometry appears to be of little help clinically in assessing the severity of the uremic bleeding diathesis.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000368:Aged; D001760:Bleeding Time; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006470:Hemorrhage / Q000175:diagnosis*; D006801:Humans; D008875:Middle Aged; D010974:Platelet Aggregation; D010979:Platelet Function Tests; D014511:Uremia / Q000097:blood*
D000244:Adenosine Diphosphate; D003404:Creatinine; D004837:Epinephrine